Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report)’s share price dropped 1.5% during trading on Thursday . The company traded as low as $0.14 and last traded at $0.14. Approximately 813 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 10,628 shares. The stock had previously closed at $0.15.
Guided Therapeutics Price Performance
The stock’s 50-day moving average is $0.17 and its 200 day moving average is $0.15. The company has a market cap of $9.30 million, a PE ratio of -4.76 and a beta of 0.58.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- Conference Calls and Individual Investors
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What Are Treasury Bonds?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 10 Best Airline Stocks to Buy
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
